Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Sensors (Basel) ; 23(16)2023 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-37631562

RESUMEN

Over the past several years, many children have died from suffocation due to being left inside a closed vehicle on a sunny day. Various vehicle manufacturers have proposed a variety of technologies to locate an unattended child in a vehicle, including pressure sensors, passive infrared motion sensors, temperature sensors, and microwave sensors. However, these methods have not yet reliably located forgotten children in the vehicle. Recently, visual-based methods have taken the attention of manufacturers after the emergence of deep learning technology. However, the existing methods focus only on the forgotten child and neglect a forgotten pet. Furthermore, their systems only detect the presence of a child in the car with or without their parents. Therefore, this research introduces a visual-based framework to reduce hyperthermia deaths in enclosed vehicles. This visual-based system detects objects inside a vehicle; if the child or pet are without an adult, a notification is sent to the parents. First, a dataset is constructed for vehicle interiors containing children, pets, and adults. The proposed dataset is collected from different online sources, considering varying illumination, skin color, pet type, clothes, and car brands for guaranteed model robustness. Second, blurring, sharpening, brightness, contrast, noise, perspective transform, and fog effect augmentation algorithms are applied to these images to increase the training data. The augmented images are annotated with three classes: child, pet, and adult. This research concentrates on fine-tuning different state-of-the-art real-time detection models to detect objects inside the vehicle: NanoDet, YOLOv6_1, YOLOv6_3, and YOLO7. The simulation results demonstrate that YOLOv6_1 presents significant values with 96% recall, 95% precision, and 95% F1.


Asunto(s)
Asfixia , Hipertermia Inducida , Adulto , Niño , Humanos , Incidencia , Hipertermia
2.
Sensors (Basel) ; 23(3)2023 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-36772561

RESUMEN

During the last decade, surveillance cameras have spread quickly; their spread is predicted to increase rapidly in the following years. Therefore, browsing and analyzing these vast amounts of created surveillance videos effectively is vital in surveillance applications. Recently, a video synopsis approach was proposed to reduce the surveillance video duration by rearranging the objects to present them in a portion of time. However, performing a synopsis for all the persons in the video is not efficacious for crowded videos. Different clustering and user-defined query methods are introduced to generate the video synopsis according to general descriptions such as color, size, class, and motion. This work presents a user-defined query synopsis video based on motion descriptions and specific visual appearance features such as gender, age, carrying something, having a baby buggy, and upper and lower clothing color. The proposed method assists the camera monitor in retrieving people who meet certain appearance constraints and people who enter a predefined area or move in a specific direction to generate the video, including a suspected person with specific features. After retrieving the persons, a whale optimization algorithm is applied to arrange these persons reserving chronological order, reducing collisions, and assuring a short synopsis video. The evaluation of the proposed work for the retrieval process in terms of precision, recall, and F1 score ranges from 83% to 100%, while for the video synopsis process, the synopsis video length compared to the original video is decreased by 68% to 93.2%, and the interacting tube pairs are preserved in the synopsis video by 78.6% to 100%.


Asunto(s)
Algoritmos , Registros , Grabación en Video/métodos , Movimiento (Física) , Análisis por Conglomerados
3.
Asian Pac J Cancer Prev ; 22(11): 3553-3559, 2021 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-34837912

RESUMEN

OBJECTIVE: to assess expression of p27 and survivin in chronic gastritis with/without H. pylori ± intestinal metaplasia (IM) and in intestinal-type gastric cancer (IGC). MATERIALS AND METHODS: Immunohistochemical staining for p27 and survivin on paraffin-embedded sections of 20 chronic gastritis, 20 H. pylori gastritis, 15 H. pylori gastritis with IM, 50 IGC, and 10 controls. Positivity (number of positive cases) and expression (mean percentage of positive gastric cells) for both proteins were evaluated. RESULTS: P27 positivity and expression decreased from control to chronic gastritis to H. pylori gastritis to H. pylori gastritis with IM. In IGC, p27 positivity and expression were lower than controls and chronic gastritis but higher than H. pylori gastritis ±IM. High grade and advanced stage IGCs have insignificantly lower p27 positivity and expression than low grade and early stage IGCs. By contrast, survivin positivity and expression increased from chronic gastritis to H. pylori gastritis to H. pylori gastritis with IM to IGCs. High grade and advanced stage IGCs have significantly higher survivin positivity and expression than low grade and early stage IGCs. Males have higher positivity and expression for p27 and survivin than females. CONCLUSION: Inverse relation between p27 and survivin in H. pylori gastritis, H. pylori gastritis with IM and IGCs lesions, suggesting that both proteins could be used as potential prognostic and/or diagnostic biomarkers in H. pylori and IM associated- gastritis as well as in IGC.


Asunto(s)
Inhibidor p27 de las Quinasas Dependientes de la Ciclina/metabolismo , Gastritis/genética , Helicobacter pylori , Neoplasias Gástricas/genética , Survivin/metabolismo , Estudios de Casos y Controles , Enfermedad Crónica , Femenino , Gastritis/microbiología , Gastritis/patología , Infecciones por Helicobacter/genética , Infecciones por Helicobacter/microbiología , Infecciones por Helicobacter/patología , Humanos , Masculino , Metaplasia , Pronóstico , Estudios Retrospectivos , Factores Sexuales , Estómago/metabolismo , Estómago/patología , Neoplasias Gástricas/microbiología , Neoplasias Gástricas/patología
4.
Front Psychiatry ; 11: 564172, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33240122

RESUMEN

The impact of the COVID-19 pandemic on mental health is likely to be significant. Identifying vulnerable groups during the pandemic is essential for targeting psychological support, and in preparation for any second wave or future pandemic. Vulnerable groups are likely to vary across different societies; therefore, research needs to be conducted at a national and international level. This online survey explored generalized anxiety and depression symptoms in a community sample of adults (N = 1,039) in the United Arab Emirates (UAE) between April 8th and April 22nd, 2020. Respondents completed symptom measures of depression (PHQ8) and generalized anxiety (GAD7), along with psychosocial and demographic variables that might potentially influence such symptoms. Bivariate and multivariate associations were calculated for the main study variables. Levels of anxiety and depression were notably higher than those reported in previous (pre-pandemic) national studies. Similar variables were statistically significantly associated with both depression and anxiety, most notably younger age, being female, having a history of mental health problems, self or loved ones testing positive for COVID-19, and having high levels of COVID-related anxiety and economic threat. Sections of the UAE population experienced relatively high levels of depression and anxiety symptoms during the early stages of the pandemic. Several COVID-related and psychosocial variables were associated with heightened symptomatology. Identifying such vulnerable groups can help inform the public mental health response to the current and future pandemics.

5.
Asian Pac J Cancer Prev ; 21(8): 2357-2366, 2020 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-32856866

RESUMEN

BACKGROUND: Colorectal cancer (CRC) is the fourth most common cancer worldwide. Both HER2 and SKP2 have a carcinogenic role in CRC making them attractive targets for tailored treatment. This work aims to correlate HER2 and SKP2 protein expression as well as HER2 gene amplification with clinicopathological parameters aiming at identifying potential candidates for targeted therapy. METHODS: This Study was conducted on 127 paraffin-embedded tissue samples of different colorectal lesions [controls, chronic colitis, ulcerative colitis (UC), hyperplastic polyps (HPs), adenomas and CRCs] to investigate HER2 and SKP2 expression by immunohistochemistry (IHC), Selected CRC cases [equivocal (2+) and positive (3+) by IHC] were further evaluated by ISH (CISH and SISH ) to assess HER2 gene amplification. RESULTS: Chronic colitis, UC, HPs and adenomas were HER2-negative. HER2 positivity (scores 2+ and 3+) was found only in15% of CRCs. Both SISH and CISH showed the same results with high concordance as 66.7% of equivocal and 100% of positive cases showed amplification of HER2 gene. SKP2 positivity was detected in 26.7% and 45% of adenomas and CRCs respectively, while other studied groups were negative. A significant correlation was noted between HER2 and SKP2 expression. CONCLUSION: A small percent of CRCs exhibited HER2 gene amplification, which would be potential candidates for anti HER2 therapy whereas IHC could be a primary screening test for patient selection. A potential carcinogenic role of SKP2 was suggested by the findings that SKP2 expression was undetectable in normal colonic mucosa but significantly increases from adenoma to carcinoma, hoping adenoma patients to get benefit from targeted therapy.
.


Asunto(s)
Adenocarcinoma/patología , Adenoma/patología , Biomarcadores de Tumor/metabolismo , Neoplasias Colorrectales/patología , Receptor ErbB-2/metabolismo , Proteínas Quinasas Asociadas a Fase-S/metabolismo , Adenocarcinoma/metabolismo , Adenoma/metabolismo , Adolescente , Adulto , Anciano , Estudios de Casos y Controles , Neoplasias Colorrectales/clasificación , Neoplasias Colorrectales/metabolismo , Diagnóstico Diferencial , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Adulto Joven
6.
Asian Pac J Cancer Prev ; 20(2): 615-620, 2019 Feb 26.
Artículo en Inglés | MEDLINE | ID: mdl-30806068

RESUMEN

Background: Prostate cancer (PCa) is a common health problem in elderly. RAGE (Receptor for advanced glycation end products) is overexpressed in multiple human cancers. SOX2 (Sex-determining region Y box 2) also functions as an oncoprotein and promotes cancer progression but the mechanisms involved remain largely unknown. Aim: The current study investigated the expression patterns of RAGE and SOX2 in benign and malignant prostate samples in correlation with the histopathological findings in order to evaluate their role as prognostic markers or therapeutic targets. Methods: Immunohistochemical staining for RAGE and SOX2 antibodies was applied on 87 prostatic biopsies [16 of prostatitis, 20 of benign prostatic hyperplasia (BPH) and 51 of PCa]. Results: Expression of RAGE and SOX2 (percentage of positive cells) was significantly higher in PCa lesions compared with prostatitis (p<0.01) and BPH (p<0.0001) and was also significantly higher in prostatitis compared with BPH lesions (p<0.01). Also, percentage of positive RAGE and SOX2 cells showed a significant stepwise increase from Gleason Grade 3 to Grade 5 and were significantly higher in high Gleason Scores (≥8) compared to lower Scores (≤7) with statistical significance (p=0.001). Conclusion: RAGE and SOX2 were up-regulated in prostate cancer lesions, mainly in advanced grades, suggesting an active role of both antigens in the development and progression of prostate cancer and expecting the possibility of their use as therapeutic targets.


Asunto(s)
Antígenos de Neoplasias/metabolismo , Biomarcadores de Tumor/metabolismo , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Hiperplasia Prostática/diagnóstico , Neoplasias de la Próstata/diagnóstico , Prostatitis/diagnóstico , Factores de Transcripción SOXB1/metabolismo , Anciano , Diagnóstico Diferencial , Estudios de Seguimiento , Humanos , Masculino , Clasificación del Tumor , Hiperplasia Prostática/metabolismo , Neoplasias de la Próstata/metabolismo , Prostatitis/metabolismo
7.
APMIS ; 126(6): 477-485, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29924446

RESUMEN

Chronic hepatitis C (CHC) is a major public health problem, especially in Egypt. Risk of hepatocellular carcinoma (HCC) development increases as hepatitis C virus (HCV)-related liver diseases progress. Smads act as substrates for the transforming growth factor-beta (TGF-ß) family of receptors. This study aims to assess hepatic expression of pSmad2/3 and Smad4 in CHC with different stages of fibrosis and grades of necro-inflammation as well as in HCC on top of CHC. This study was done on 33 core liver biopsies from patients with CHC (15 with early fibrosis and 18 with late fibrosis), 15 liver specimens from HCC cases on top of CHC, as well as five normal controls. pSmad2/3 and Smad4 show more immunopositivity, higher percentage of positive hepatocytes and stronger staining intensity in CHC with late fibrosis compared to early fibrosis. pSmad2/3 shows increase of the previous parameters in CHC with high grade activity than those with low activity. Smad4 shows increase of the previous parameters in HCC compared to CHC cases. pSmad2/3 and Smad4 can be used as diagnostic and/or prognostic markers for progression of HCV-related fibrosis to cirrhosis and further progression to HCC.


Asunto(s)
Carcinoma Hepatocelular/genética , Cirrosis Hepática/genética , Neoplasias Hepáticas/genética , Proteína Smad2/metabolismo , Proteína smad3/metabolismo , Proteína Smad4/metabolismo , Adulto , Anticuerpos Antivirales/sangre , Antígenos Virales/sangre , Carcinoma Hepatocelular/diagnóstico , Carcinoma Hepatocelular/virología , Estudios de Casos y Controles , Progresión de la Enfermedad , Femenino , Regulación de la Expresión Génica , Hepacivirus/aislamiento & purificación , Hepatitis C/diagnóstico , Hepatitis C/genética , Humanos , Inmunohistoquímica , Cirrosis Hepática/diagnóstico , Cirrosis Hepática/virología , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/virología , Masculino , Persona de Mediana Edad , Proteína Smad2/genética , Proteína smad3/genética , Proteína Smad4/genética , Adulto Joven
8.
Hepatol Int ; 12(1): 75-82, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29185106

RESUMEN

BACKGROUND AND AIMS: Band ligation and propranolol are the current therapies for primary prevention of variceal bleeding. Carvedilol is a rising nonselective beta-blocker used for reducing portal pressure with favorable outcome. The aim of this study to assess the efficacy of carvedilol, propranolol, and band ligation for primary prevention of variceal bleeding based on the effect of each regimen on progression of Child score and portal hypertensive gastropathy after 1 year. METHODS: The study included 264 cirrhotic patients with medium/large-sized varices who were candidates for primary prophylaxis of variceal bleeding. Patients were randomly divided into three groups: group I: band ligation; group II: propranolol; group III: carvedilol. RESULTS: Group I showed higher success rate of 75 %, followed by group III with 70.2 % and group II with 65.2 %. Risk of bleeding was comparable between the three groups, with group II carrying the highest rate of complications (34.7 %) followed by group III (14.2 %) and finally group I (5.7 %). After 1 year of follow-up, Child score did not improve in any of the studied groups, while portal hypertensive gastropathy significantly increased in group I but decreased in groups II and III. CONCLUSIONS: Band ligation is the best treatment option for primary prevention of variceal bleeding with minimal complications. Carvedilol is a good pharmaceutical alternative medicine to propranolol with lesser side-effects. Progress of liver disease as represented by Child score is not affected by any of the primary variceal prophylactic regimens, although medical treatment reduces portal hypertensive gastropathy. Choice of treatment depends on patient will, compliance with treatment, and endoscopist competence.


Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Carbazoles/uso terapéutico , Várices Esofágicas y Gástricas/prevención & control , Hemorragia Gastrointestinal/prevención & control , Propanolaminas/uso terapéutico , Propranolol/uso terapéutico , Antagonistas Adrenérgicos beta/administración & dosificación , Adulto , Anciano , Carbazoles/administración & dosificación , Carvedilol , Egipto , Várices Esofágicas y Gástricas/mortalidad , Femenino , Hemorragia Gastrointestinal/mortalidad , Humanos , Ligadura , Masculino , Persona de Mediana Edad , Propanolaminas/administración & dosificación , Propranolol/administración & dosificación , Resultado del Tratamiento
9.
Curr Urol ; 9(4): 192-201, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28413380

RESUMEN

INTRODUCTION: Overexpression of epidermal growth factor receptor (EGFR) has been described in several solid tumors including bladder cancer. Transforming growth factor alpha (TGFα) is frequently deregulated in neoplastic cells and plays a role in the development of bladder cancer. TGFα-EGFR ligand-receptor combination constitutes an important event in multistep tumorigenesis. METHODS: This study was done on 30 bladder biopsies from patients with urothelial carcinoma, 15 with squamous cell carcinoma, 10 with cystitis and 5 normal control bladder specimens. All were immuohistochemically stained with EGFR and TGFα antibodies. RESULTS: EGFR and TGFα were over-expressed in higher grades and late stages of bladder cancer. Moreover, they show higher expression in squamous cell carcinoma compared to urothelial carcinoma and in schistosomal associated lesions than in non-schistosomal associated lesions. CONCLUSION: EGFR and TGFα could be used as prognostic predictors in early stage and grade of bladder cancer cases, especially those with schistosomal association. In addition they can help in selecting patients who can get benefit from anti-EGFR molecular targeted therapy.

10.
APMIS ; 123(10): 823-31, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26279457

RESUMEN

Epidermal growth factor receptor system plays a central hepato-protective and pro-regenerative role in liver. Transforming growth factor-α (TGF-α) is an important autocrine growth regulator of hepatocytes that plays a role in development of hepatocellular carcinoma (HCC) among patients with chronic hepatitis C (CHC). This study was done on 40 core liver biopsies from patients with CHC, 20 liver specimens from HCC cases on top of CHC as well as five normal controls. All were immunohistochemically stained with epidermal growth factor receptor (EGFR) and TGF-α antibodies. Some selected HCC cases were submitted for FISH technique to detect EGFR gene alteration. By immunohistochemistry EGFR and TGF-α were overexpressed in HCC and cirrhotic cases compared to CHC cases without cirrhosis. Also, their expression was stronger in CHC cases with higher grades of activity and stages of fibrosis compared to lower ones. FISH positive results for EGFR were detected in 33.3% of the examined HCC cases. EGFR and TGF-α can be used as predictive markers for activity, fibrosis, and carcinogenesis in CHC patients. Overexpression of EGFR in HCC patients can be promising in selecting those who can get benefit from anti-EGFR target therapy.


Asunto(s)
Carcinoma Hepatocelular/virología , Receptores ErbB/metabolismo , Hepatitis C Crónica/virología , Neoplasias Hepáticas/virología , Factor de Crecimiento Transformador alfa/metabolismo , Adulto , Anciano , Biomarcadores de Tumor/genética , Biomarcadores de Tumor/metabolismo , Carcinoma Hepatocelular/metabolismo , Receptores ErbB/genética , Femenino , Hepacivirus/patogenicidad , Hepatocitos/metabolismo , Humanos , Hibridación Fluorescente in Situ , Cirrosis Hepática/metabolismo , Cirrosis Hepática/virología , Neoplasias Hepáticas/metabolismo , Masculino , Persona de Mediana Edad
11.
J Adv Res ; 6(2): 163-9, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25750750

RESUMEN

This paper presents a fast and simple method for human action recognition. The proposed technique relies on detecting interest points using SIFT (scale invariant feature transform) from each frame of the video. A fine-tuning step is used here to limit the number of interesting points according to the amount of details. Then the popular approach Bag of Video Words is applied with a new normalization technique. This normalization technique remarkably improves the results. Finally a multi class linear Support Vector Machine (SVM) is utilized for classification. Experiments were conducted on the KTH and Weizmann datasets. The results demonstrate that our approach outperforms most existing methods, achieving accuracy of 97.89% for KTH and 96.66% for Weizmann.

12.
Clin Biochem ; 45(1-2): 112-6, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21933669

RESUMEN

OBJECTIVES: Acute lymphoblastic leukemia (ALL) is an aggressive cancer especially in adults as only 20-40% are cured with current treatment regimens. DESIGN AND METHODS: We measured survivin and tumor necrosis factor-alpha (TNF-α) in serum of 30 ALL patients before and after induction therapy and compared to 30 age and sex matched normal adults. RESULTS: Survivin at cutoff value 15.18 pg/mL was detected in all ALL patients before therapy but in only 83.33% after therapy and not detected in the control group; P<0.001. However TNF-α at cutoff value 60.05 pg/mL was detected in 90% ALL patients before therapy and 86.6% after therapy that was significantly higher than the control group (20%); P<0.001. Survivin showed a significant positive correlation with TNF-α (P<0.05), bone marrow blast cells (P<0.01), peripheral blast cells (P<0.05) and Philadelphia chromosome (P<0.01). CONCLUSIONS: Survivin may have an important role in the development of acute leukemia and it could serve as a significant prognostic marker.


Asunto(s)
Proteínas Inhibidoras de la Apoptosis/sangre , Leucemia-Linfoma Linfoblástico de Células Precursoras/sangre , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética , Factor de Necrosis Tumoral alfa/sangre , Adulto , Biomarcadores de Tumor , Femenino , Regulación Leucémica de la Expresión Génica , Humanos , Masculino , Persona de Mediana Edad , Cromosoma Filadelfia , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Pronóstico , Curva ROC , Factores de Riesgo , Sensibilidad y Especificidad , Survivin , Resultado del Tratamiento
13.
Arch Med Sci ; 6(3): 356-65, 2010 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-22371771

RESUMEN

INTRODUCTION: α-Smooth muscle actin (α-SMA)-positive hepatic stellate cells (HSCs) are pericytes responsible for fibrosis in chronic liver injury. The glial fibrillary acidic protein (GFAP), commonly expressed by astrocytes in the central nervous system, is expressed in vivo in the liver in a subpopulation of quiescent stellate cells. The reports concerning GFAP expression in human liver are still conflicting. The aim of the study is investigation the utility of GFAP compared to α-SMA as an indicator of early activated HSCs, in predicting fibrosis in chronic hepatitis C (CHC) patients. MATERIAL AND METHODS: With immunohistochemistry and a semi-quantitative scoring system, the expressions of α-SMA and GFAP on HSCs in liver biopsies from patients with pure CHC (n = 34), hepatitis C virus-induced cirrhosis (n = 24), mixed CHC/schistosomiasis (n = 11) and normal controls (n = 10) were analysed. RESULTS: The immunoreactivity of α-SMA and GFAP in perisinusoidal, periportal and pericentral areas was assessed. α-Smooth muscle actin and GFAP-positive HSCs were significantly increased in all diseased groups compared with normal controls. In pure CHC with or without cirrhosis, perisinusoidal α-SMA-positive HSCs were predominant in relation to GFAP-positive cells. On the other hand, GFAP-positive cells were predominant in the group of schistosomiasis as compared with the other diseased groups. It was noticed that expression of GFAP on perisinusoidal HSCs in CHC patients sequentially decreased with the progression of fibrosis. CONCLUSIONS: Glial fibrillary acidic protein could represent a more useful marker than α-SMA of early activation of HSCs in CHC patients and seems to be an early indicator of hepatic fibrogenesis.

14.
APMIS ; 117(1): 45-52, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19161536

RESUMEN

Cyclooxygenase-2 (COX-2) is a key inducible enzyme involved in the production of prostaglandins. It contributes to human carcinogenesis by various mechanisms. The aim of the current study was to elucidate the possible involvement of COX-2 in human bladder carcinoma by examining its expression on both urothelial and inflammatory cells in tissue biopsies and urine cytology samples of different urinary bladder lesions. A total of 65 patients were included in the study and were selected from cases admitted to Urology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt. They represented seven control cases with almost normal-looking bladder tissue; pure chronic cystitis (n=12); premalignant lesions (18) in the form of squamous metaplasia (n=8) or urothelial dysplasia (n=10) as well as transitional cell carcinoma (TCC) (n=18), and squamous cell carcinoma (SqCC) (n=10). Immunohistochemistry of formalin-fixed, paraffin-embedded tissue sections and urine cytology samples was performed for all cases using COX-2 (H-62): sc-7951, a rabbit polyclonal antibody. The study revealed positive COX-2 expression on the urothelial and inflammatory cells of cystoscopic biopsies from all cases of pure chronic cystitis, squamous metaplasia and SqCC compared with 42.8% and 71.4% of normal controls, respectively. The score of urothelial COX-2 expression was sequentially up-regulated from normal to chronic cystitis (either pure or associated with premalignant changes) (p<0.05) to malignant changes (p<0.05). However, the inflammatory cellular expression was down-regulated with malignant transformation compared with chronic cystitis (p<0.05). In TCC, COX-2 was over-expressed on both urothelial and inflammatory cells in advanced tumors. Urine cytology samples were positive for COX-2 in a comparable manner to that observed in cystoscopic biopsies. Accordingly, the results of the current study have provided new information in two aspects: First, is the possibility of using the differential COX-2 expression on both inflammatory and urothelial cells as markers for premalignant or malignant transformation; second, besides cystoscopy, urine cytology was found to have a high sensitivity for COX-2 expression and hence proved to be valuable in malignancy as a non-invasive substitute for cystoscopy.


Asunto(s)
Biomarcadores de Tumor/biosíntesis , Biomarcadores de Tumor/orina , Carcinoma de Células Escamosas/enzimología , Carcinoma de Células Escamosas/orina , Carcinoma de Células Transicionales/enzimología , Carcinoma de Células Transicionales/orina , Ciclooxigenasa 2/biosíntesis , Ciclooxigenasa 2/orina , Neoplasias de la Vejiga Urinaria/enzimología , Neoplasias de la Vejiga Urinaria/orina , Adulto , Anciano , Carcinoma de Células Escamosas/patología , Carcinoma de Células Transicionales/patología , Femenino , Humanos , Inmunohistoquímica , Inflamación/enzimología , Inflamación/patología , Masculino , Persona de Mediana Edad , Lesiones Precancerosas/enzimología , Lesiones Precancerosas/patología , Lesiones Precancerosas/orina , Neoplasias de la Vejiga Urinaria/patología , Orina/citología , Urotelio/enzimología , Urotelio/patología
15.
J Infect ; 55(5): 470-7, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17868901

RESUMEN

OBJECTIVE: To investigate immune mechanisms possibly involved in the amelioration of histopathological changes in livers of Schistosoma mansoni-infected mice treated with artemether (ART), including liver functions and apoptotic changes. METHODS: Male CD-1 Swiss albino mice were infected with Schistosoma mansoni and treated with praziquantel (PZQ) 6 weeks post-infection (PI) (500 mg/kg/day x2) and/or ART in double dose (each of 400 mg/kg) 4 and 6 weeks PI. Parasitological parameters, liver functions and histopathological changes including T-lymphocyte profile and apoptotic changes were assessed. RESULTS: Eight weeks PI, although the reduction in worm burden in mice treated with ART plus PZQ was comparable to that in PZQ-treated mice, yet there was complete absence of eggs and typical granulomas. The ratio of T-helper/cytotoxic cells was in favor of T-helper in infected control and in mice treated with both drugs. This ratio was 0.9:1 and 0.7:1 in PZQ and ART-treated groups, respectively, with moderate apoptotic changes in the latter. All biochemical parameters expressing liver function were improved with all treatment regimens. CONCLUSIONS: Administration of ART in addition to PZQ resulted in absence of eggs and typical granulomas with less apoptotic changes than in ART-treated mice. Improved liver functions with higher apoptosis in ART-treated mice may suggest enhanced necrotic cell death/regenerative changes.


Asunto(s)
Artemisininas/uso terapéutico , Esquistosomiasis mansoni/inmunología , Esquistosomiasis mansoni/patología , Esquistosomicidas/uso terapéutico , Animales , Apoptosis , Arteméter , Granuloma/patología , Histocitoquímica , Hígado/patología , Hígado/fisiopatología , Pruebas de Función Hepática , Masculino , Ratones , Recuento de Huevos de Parásitos , Praziquantel/uso terapéutico , Esquistosomiasis mansoni/tratamiento farmacológico , Subgrupos de Linfocitos T/citología , Subgrupos de Linfocitos T/inmunología
16.
J Surg Res ; 138(1): 88-99, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17174338

RESUMEN

BACKGROUND: Prostaglandin E1 (PGE1) is known to protect the liver from I/R, however, the mechanism of cytoprotection is not well understood. This study investigates the effect of intraportal infusion of PGE1 in a warm liver ischemia/reperfusion (I/R) model on cytokines, adhesion molecules and liver structure. MATERIALS AND METHODS: Twenty dogs underwent laparotomy under general anesthesia. PGE1 (0.02 microg\kg\min) was perfused through the portal vein in the PGE1 group (n = 10), or a similar volume of Ringer's solution in the control group (n = 10) for 15 min. Liver ischemia was induced by hepatic artery and portal vein occlusion and PGE1 was infused via the portal vein for 60 min. The occlusion was released and PGE1 infusion recommenced for 30 min. Blood and liver biopsies were sampled at baseline, 60 min ischemia, and 30 min reperfusion and assessed for transaminases, cytokines, adhesion molecules, and electron microscopy. RESULTS: PGE1 infusion significantly reduced transaminases TNF-alpha, sICAM-1, sP-selectin, and sE-selectin on ischemia and reperfusion. PGE1 reduced hepatocytic degeneration, portal and central ICAM-1 expression, central and sinusoidal VCAM-1 expression, portal and central P-selectin expression, and portal and sinusoidal E-selectin expression on reperfusion. CONCLUSION: Intraportal PGE1 infusion reduced I/R injury and was associated with down-regulation of ICAM-1, VCAM-1, P-selectin, and E-selectin on reperfusion.


Asunto(s)
Alprostadil/farmacología , Moléculas de Adhesión Celular/metabolismo , Mediadores de Inflamación/metabolismo , Daño por Reperfusión/tratamiento farmacológico , Vasodilatadores/farmacología , Animales , Biopsia , Perros , Selectina E/metabolismo , Femenino , Hepatocitos/patología , Hepatocitos/ultraestructura , Molécula 1 de Adhesión Intercelular/metabolismo , Hígado/efectos de los fármacos , Hígado/inmunología , Hígado/patología , Masculino , Microscopía Electrónica , Selectina-P/metabolismo , Vena Porta , Daño por Reperfusión/inmunología , Daño por Reperfusión/patología , Molécula 1 de Adhesión Celular Vascular/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...